Chuangyebang was informed that recently, Hangzhou LinkZill Technology Co., Ltd. (LinkZill, hereinafter referred to as LinkZill Technology) completed tens of millions of RMB Pre-A+ round financing led by Xingze Capital and followed by Zhen Fund. Yunxiu Capital acted as the exclusive financial advisor for this round of financing. This round of financing will be mainly used to continue to promote the application of TFT semiconductor chips in the field of life sciences.
LinkZill was established in Wuhan in January 2019, relocated to Hangzhou in January 2020, and established a Shanghai R&D center in 2021. LinkZill Technology takes “leading technology, sincerity and integrity” as its core value, and is committed to making technology better serve people, adhering to Linking zillions of people and technology. Linking zillions of hearts with love (Linking zillions of people and technology, linking countless loving hearts).
LinkZill takes Thin Film Transistor (TFT) semiconductor chips (including supporting driving and testing systems and functional materials) as its core products and technologies, and focuses on its industrial applications in cross-cutting fields such as life science and sensor display. It covers digital microfluidics, high-throughput in vitro diagnostic testing, biosensing, high-throughput DNA synthesis, brain-computer interface, and frontier research on photoelectric sensing and display. So far, LinkZill has served hundreds of global technology companies, universities and research institutes through the core technology of TFT chips, and has accumulated comprehensive three-dimensional technical capabilities and industrialization experience from chip design, simulation, process to system integration. The core team members of LinkZill come from Shanghai Jiaotong University, Cambridge University, University of Florida, Huazhong University of Science and Technology and other well-known universities at home and abroad.
At present, the market size of the global biochip field is close to 20 billion US dollars and is in the process of rapid development, and it may reach a market size of 100 billion US dollars in the future. The TFT biochips developed by LinkZill for typical applications in the field of life sciences have been gradually introduced and matured on the client side. With the establishment of the company’s biological team and the gradual establishment of biological laboratories, more new application scenarios are also Synchronous development.
Dr. Qiang Jing, founding partner of Xingze Capital, said: Xingze Capital has always paid attention to new platforms and new technologies in the frontier life sciences, especially breakthroughs in cross-cutting fields. Based on the advantages of thin film transistor technology such as strong scalability, flexibility and low cost, LinkZill actively develops its applications in different scenarios in the field of life sciences. In upstream scientific research, consensus has long been formed, and a series of refreshing technologies have been born, and there are a large number of unmet biomedical needs downstream. Therefore, there is an urgent need for a group of forward-thinking and underlying technical teams to provide new solutions through technology integration and engineering. We believe that LinkZill is an excellent team with the above characteristics, and will develop a series of products with paradigmatic innovations in the field of life sciences in the future.
Yin Le, partner of ZhenFund, said: Since July 2021, ZhenFund has chosen to support LinkZill in two consecutive rounds of financing. I see the shadow of “disruptive innovation” in what LinkZill does, and I also see the amazing cohesion brought by the culture drive from the team of LinkZill. LinkZill is destined to experience the ups and downs of entrepreneurship in this era. The highs and lows will continue to switch with the development of LinkZill. I look forward to witnessing this magical journey of LinkZill and the brave exploration of “surrendering to the flow of life”.
Dr. Yang Xingxing, Partner and Chief Marketing Officer of LinkZill, said: “I am very fortunate that the first time in my life that I personally participated in the company’s financing can finally win the trust and support of Xingze. Thanks to Xingze and the past true and ten-dimensional partners who can still firmly believe in our utopian future dream of bio-semiconductors, can still understand our obsession for the realization of our dreams, and can still be tolerant as always The imperfections in us along the way. Thank you for your company, thank you for your companions.
Dr. Feng Linrun, founder and CEO of LinkZill, said: From the “ten-dimensional” “life has infinite possibilities and multiple dimensions”, to the “true” “our business is genuine”, and then to “Xingze” It is precisely because of the support of these lovely institutions that the “leading technology, sincerity and sincerity” of “Lingzhi” has gradually become a reality from a slogan. Along the way, I want to thank too much, and feel fortunate too many moments, ups and downs, warm and cold. With the gradual formation of the team and the completion of the Pre-A+ round of financing, LinkZill will surely face greater challenges from all aspects. I know that I am not fully ready, and may never be fully ready, but looking at the friends and family who have accompanied me along the way, I have the courage to look up at the sky and the determination to be down-to-earth.
media coverage
Start -up in the investment world
Related events
- ” LinkZill Technology” completed tens of millions of yuan in Pre-A+ round of financing to promote the application of TFT chips in life sciences2022-09-05
- Xuanren Technology announced the completion of Pre-A round of financing2021-10-29
This article is reprinted from: https://readhub.cn/topic/8j3qaMa5Dka
This site is for inclusion only, and the copyright belongs to the original author.